MedNews

Recent Postings

Oct 9, 20244 min read

MedNews: Nyxoah raises $27 million for its breakthrough treatment alternatives for Obstructive Sleep Apnea through neuromodulation

Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA).

Sep 9, 20243 min read

MedNews: CSA Medical raises $53 million to advance its RejuvenAir System utilizing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis

This round will fund the company though expected FDA premarket approval and the building of a commercialization strategy

Aug 23, 20243 min read

MedNews: XII MEDICAL closes $45 million financing to advance its neuromodulation therapy for obstructive sleep apnea

It is estimated that 425 million people, globally, have moderate to severe obstructive sleep apnea

Aug 22, 20243 min read

MedNews: Retension Pharmaceuticals raises $10.4 million to fund clinical trials for patients suffering from resistant and uncontrolled hypertension

Retension Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing RTN-001 as a therapy for patients with hypertension.

Aug 11, 20243 min read

MedNews: EHE Health, the leader in employer-based preventive healthcare is acquired by Consello Capital

EHE's comprehensive, evidence-based preventive care provides 100% of the recommended screenings, resulting in more health conditions being f

Aug 8, 20243 min read

TechNews: Cyclotron technology innovator and isotope manufacturer IONETIX closes financing led by Tees River and Eli Lilly and Company

distribution supply chain includes contract drug manufacturing and "white glove" distribution logistics, allowing global access...

Aug 4, 20243 min read

MedNews: Clinical biopharmaceutical company Sellas Life Sciences, focused on the development of novel therapies for a broad range of cancer indications, raises $21 million

SELLAS is a clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications

Jul 27, 20245 min read

MedNews: AI-enabled biotechnology company ReviR Therapeutics raises $30 million to advance oral genetic medicines for multiple CNS disorders

ReviR Therapeutics is a biopharmaceutical company focused on the development of RNA-targeting small molecule therapies

Jul 25, 20243 min read

MedNews: clinical-stage biotherapeutics company Rani Therapeutics, focused on the oral delivery of biologics and drugs, prices $10 million offering

Our mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful injections with a pill

Jul 10, 20246 min read

ReShape Lifesciences, a weight loss and metabolic health-solutions company to merge with clinical stage specialty pharmaceutical company Vyome, and acquire assets of metabolic health Biorad Medisys

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and Vyome Therapeutics,

Jul 6, 20243 min read

MedNews: Adult stem cell therapeutics developer BrainStorm Cell Therapeutics (Nasdaq: BCLI) raises $4 million

Autologous MSC-NTF cells have received Orphan Drug designation status from the FDA and the European Medicines Agency

Jul 1, 20241 min read

MedTalks - An interview with Brian Frenzel, CEO of TOSK discussing the company's business and its investment opportunities

TK-90 has completed “proof of concept” in Phase 2a clinical studies demonstrating safety and efficacy in head and neck cancer patients...

Jun 30, 20244 min read

MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease

The company’s discovery engine builds on Dr. Choe’s research uncovering a unique pheromone language shared by roundworms

Jun 18, 20243 min read

MedNews: Ehealth Technologies partners with CancerX and the White House cancer moonshot to boost cancer innovation

Our patented technology with embedded AI collects and clinically organizes patient data, including records, lab results, images...

Jun 16, 20244 min read

MedNews: Avinger (Nasdaq: AVGR) prices share and warrant offering of up to $24 million at $1.66 per share

Avinger is a medical device company that has developed the first image-guided, catheter-based system for patients with vascular disease.

Jun 14, 20245 min read

MedNews: InduPro raises $85 Million to advance next-generation, proximity-based protein therapeutics for the treatment of cancer and autoimmune diseases

The financing will support the advancement of the first expected clinical product candidate targeting cancer tissue

Jun 10, 20243 min read

MedNews: Employee well being technology provider Navigate Wellbeing partners with content solution provider Caravan Wellness to benefit employees

This collaboration focuses on innovative workplace wellness programs, financial well-being education, mental and emotional health...

Jun 8, 20243 min read

MedNews: Immuno-pharma research and development company, AIM ImmunoTech raises $2 million from one investor

The Company’s lead product is a first-in-class investigational drug for cancers, viral diseases and disorders of the immune system

Jun 6, 20243 min read

MedNews: BMI OrganBank announces promising preclinical kidney transplant data for a novel medical device to reduce the wait-list for organ transplants

BMI OrganBank develops novel perfusion systems that can preserve and recondition organs and tissues.

Jun 1, 20242 min read

MedNews: GRIT Biotechnology and Quangang Pharmaceutical partner to jointly develop a globally standardized IL-2 for solid tumor patients receiving T-cell therapy

Grit is a clinical stage cell therapy company leading the tumor infiltrating lymphocytes (TILs) therapy development